Skip to main content
PolicySpeak
← All files
CI

Cryos International

Company · Denmark · EU Transparency Register 963595828688-36

1
position filed
in the 583 files tracked
1
legislative file
of 583 tracked
1
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.

Who they are

Among the 1048 companies & groups on this site, they rank #757 by legislative files engaged — a count of participation, not a measure of influence.

0.8
declared lobbying FTE
self-declared
€25K+
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2017
in the register since

Declares membership of

  • DANSK ERHVERV T. +45 3374 6000
  • CONFEDERATION OF DANISH ENTERPRISE
  • SQUARE DE MEEÛS 22B
  • B-1050 BRUXELLES
  • WWW.DANSKERHVERV.DK
  • INFO@DANSKERHVERV.DK

Self-declared to the EU Transparency Register (snapshot 2 Sept 2026).

Register category
Companies & groups
Registered as
Cryos International Aps (Cryos)
Head office
Aarhus C., Denmark

Self-declared to the EU Transparency Register (snapshot 2 Sept 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.

Track Cryos in PolicySpeak: request access →

Work at Cryos International? so we know who speaks for it.

Follow the file Cryos International engages with

One email on Tuesdays when a new position is filed on this file, from Cryos International or from anyone else on it. Only when there is something new.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Their record over time

Cryos International filed 1 position on 8 Sept 2022, across 1 of the 583 legislative files tracked here, attaching a full position paper 1 time.

What they argued

Standards of quality and safety for substances of human origin intended for human applicationfiled 8 Sept 2022PDFsource

Cryos International Sperm & Egg Bank agrees on the identified shortcomings and inadequacies in the current European Tissues and Cells Directive and implementing Directives and welcomes update of the current legislation to allow for more flexible alignment to scientific and technological developments. Cryos appreciates that policy option 2 is chosen to solve the current challenges.

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Put Cryos International next to another organization. Same files, same register facts, side by side. Compare →

Is this your organization?

Everything on this page comes from Cryos International’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.